| (CAD) | Dec 2023 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -783.25K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ARCH.V returned -34.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -12.3% |
| 1 year | -34.8% |
| 5 years | -38.9% |
| 10 years | +125.3% |
| All-time high | $4.69 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ARCH.V would be worth today ›No. Arch Biopartners Inc. has not paid a dividend in the past 12 months.
Arch Biopartners Inc. is part of the Healthcare sector.
Arch Biopartners Inc. has a market cap of 72.69M CAD, based on the latest quote.
Arch Biopartners Inc. is expected to report earnings around Aug 28, 2026. That date is an estimate and has not been confirmed by the company.
